Topic: cardiovascular risks
The FDA warned physicians of death and stroke risks associated with the external pneumatic driver system for SynCardia’s temporary artificial heart.
Boston Scientific bought cardiac cryoablation devicemaker Cryterion, a company the medical device giant has invested in since its launch in 2016.
Researchers have uncovered clues into how a genetic variant raises the risk of migraines, coronary artery disease and other related disorders.
AstraZeneca’s Fit2Me program is spreading its wings. The program is being extended to include resources for patients dealing with issues that come along with cardiovascular risk and disease.